Calcium Antagonists and Tumor Cell Lines
Author Information
Author(s): S.P.C. Cole, H.F. Downes, M.L. Slovak
Primary Institution: Ontario Cancer Treatment and Research Foundation
Hypothesis
Can calcium antagonists enhance the sensitivity of multidrug-resistant tumor cell lines to adriamycin?
Conclusion
Calcium antagonists like verapamil and nicardipine showed only modest effects in enhancing adriamycin sensitivity in multidrug-resistant tumor cell lines.
Supporting Evidence
- Verapamil showed a modest dose-dependent chemosensitising effect in HT1080/DR4 cells.
- H69AR cells showed cross-resistance to chloroquine and clomiphene.
- Only verapamil and nicardipine enhanced adriamycin cytotoxicity in H69AR cells slightly.
Takeaway
The study tested if certain drugs could help cancer cells that are resistant to treatment become more sensitive to a common chemotherapy drug. They found that the drugs didn't work as well as hoped.
Methodology
The study involved testing eight compounds for their ability to enhance the sensitivity of two human tumor cell lines and their multidrug-resistant variants using the MTT assay.
Limitations
The effects of the chemosensitisers were modest and not consistently dose-dependent, suggesting limited potential for reversing drug resistance.
Want to read the original?
Access the complete publication on the publisher's website